We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study: FDA Approves Cancer Drugs Faster, More Frequently Than EU
Study: FDA Approves Cancer Drugs Faster, More Frequently Than EU
June 24, 2011
The FDA approves cancer drugs faster and in larger numbers than the European Medicines Agency (EMA), despite recent criticism citing slow review times and risk-aversion, a study says.